Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Troy E. Messick0
Paul M. Lieberman0
Yan Zhang0
Venkata Velvadapu0
Allen B. Reitz0
Garry R. Smith0
Mark E. McDonnell0
Date of Patent
January 2, 2018
0Patent Application Number
150362110
Date Filed
November 14, 2014
0Patent Primary Examiner
Patent abstract
The invention provides EBNA1 inhibitors, and pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by EBNA1 activity such as, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and/or rheumatoid arthritis. The compounds and compositions of the invention are further useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection. The compounds and compositions of the invention are further useful for the treatment of diseases caused by lytic EBV infection.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
